It influences energy, communication, and flow. When audio is planned correctly, it supports the celebration rather than competing with it” — Don Tucker SLIDELL, LA, UNITED STATES, January 2, 2026 ...

† Biodesign Center for Personalized Diagnostics, the Biodesign Institute, Arizona State University, 727 E. Tyler Street, Tempe, Arizona 85281, United States ‡ College of Laboratory Medicine, Tianjin ...

The complement system, consisting of three initiating pathways—classical, lectin and alternative, is an important part of innate immunity. Dysregulation of the complement system is implicated in the ...

Sitala Bio Ltd. has prepared new indole derivatives acting as complement factor B (CFB) inhibitors. They are thus reported to be useful for the treatment of age-related macular degeneration, ...

This important work advances our understanding of factors influencing efficacy assessments and biomarker viability for complement-directed gene therapy against age-related macular degeneration. The ...

Temporal expression of factor I (FI) in vitreous humor (VH) and aqueous humor (AH) after PPY988 delivery. (A,B) FI levels (y-axis, ng/mL) in VH were significantly increased at week 36 and 96 ...

The report also covers products from therapy areas such as Immunology, Genito Urinary System, Hematological Disorders, and Ophthalmology which include the indications Lupus Nephritis, Anti-Neutrophil ...

∥ Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio 44195, United States ⊥ Jiansu Key Laboratory of Drug Design and Optimization ...

Complement factor B (CFB) inhibitors are described in a Novartis AG patent and reported to be useful for the treatment of age-related macular degeneration, diabetic retinopathy and eye disorders, ...

A recent article posted to the medRxiv* preprint server discussed the role of complement factor H-related protein 5 (CFHR5) in venous thromboembolism (VTE) patients and hospitalized coronavirus ...

After mild traumatic brain injury (TBI), a molecule called complement factor C1q may play a role in the secondary effects of brain injury, such as sleep disruption, epileptic activity, and ...